Milestone Pharmaceuticals Inc. (MIST) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MIST Revenue Growth
MIST Revenue Analysis (2017–2025)
As of May 8, 2026, Milestone Pharmaceuticals Inc. (MIST) generated trailing twelve-month (TTM) revenue of $1.4 million. The most recent quarter (Q4 2025) recorded $1.4 million in revenue.
Looking at the longer-term picture, MIST's historical revenue data shows a 3-year CAGR of -32.4%. The company achieved its highest annual revenue of $15.0 million in 2021.
When compared to Healthcare sector peers including ACAD (+9.9% YoY), XENE (-100.0% YoY), and INVA (+13.6% YoY). Compare MIST vs ACAD →
MIST Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MISTCurrent | $1M | - | - | -4019.4% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 XENE | $8M | -100.0% | -25.3% | -4974.3% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% | |
 IDYA | $219M | +3118.1% | +62.1% | -72.8% |
MIST Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.5M | - | $0 | - | $-62,140,000 | -4019.4% |
| 2024 | $0 | -100.0% | $0 | - | $-42,102,000 | - |
| 2023 | $1.0M | -80.0% | $1.0M | 100.0% | $-61,098,000 | -6109.8% |
| 2022 | $5.0M | -66.7% | $5.0M | 100.0% | $-59,642,000 | -1192.8% |
| 2021 | $15.0M | - | $15.0M | 100.0% | $-43,073,000 | -287.2% |
| 2020 | $0 | - | $0 | - | $-50,710,000 | - |
| 2019 | $0 | - | $0 | - | $-57,881,000 | - |
| 2018 | $0 | - | $-10,000 | - | $-23,822,000 | - |
| 2017 | $0 | - | $-8,000 | - | $-8,268,000 | - |
See MIST's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MIST Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MIST vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMIST — Frequently Asked Questions
Quick answers to the most common questions about buying MIST stock.
Is MIST's revenue growth accelerating or slowing?
MIST TTM revenue: $1M. YoY growth: N/A. 5-year CAGR: N/A.
What is MIST's long-term revenue growth rate?
Milestone Pharmaceuticals Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is MIST's revenue distributed by segment?
MIST reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.